NVAX FY 2011 Earnings — Novavax, Inc. Revenue & Financial Results | Market Cap Arena

NVAXNovavax, Inc.

$2B

FY 2011 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$15M+4182.2% YoY

Gross Profit

$8M52.3% margin

Operating Income

-$22M-146.9% margin

Net Income

-$19M-131.8% margin

EPS (Diluted)

$-3.41

Cash Flow

Operating Cash Flow

-$24M

Free Cash Flow

-$24M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$67M

Total Liabilities

$13M

Stockholders' Equity

$54M

Cash & Equivalents

$14M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$15M	$343,000	+4182.2%
Gross Profit	$8M	$343,000	+2140.5%
Operating Income	-$22M	-$38M	+43.9%
Net Income	-$19M	-$36M	+45.8%